Complete response of relapsed systemic and cutaneous anaplastic large cell lymphoma using brentuximab vedotin: 2 case reports.

Complete response of relapsed systemic and cutaneous anaplastic large cell lymphoma using brentuximab vedotin: 2 case reports.

Item
http://www.wikidata.org/entity/Q44798311
Single-Fraction Radiotherapy for CD30(+) Lymphoproliferative Disorders.Brentuximab vedotin for treatment of non-Hodgkin lymphomas: A systematic review.Targets, Toxins, and T Cells--a Review of New Monoclonal Antibodies in the Treatment of Peripheral T Cell Lymphomas.Brentuximab vedotin in CD30(+) primary cutaneous T-cell lymphomas: a review and analysis of existing data.KIR3DL2 (CD158k) is a potential therapeutic target in primary cutaneous anaplastic large-cell lymphoma.Brentuximab vedotin in CD30+ cutaneous lymphoma: How do we treat - How shall we treat? A review of the literature.Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma.Monoclonal antibodies against cutaneous T-cell lymphomas.
P2860

Complete response of relapsed systemic and cutaneous anaplastic large cell lymphoma using brentuximab vedotin: 2 case reports.

Item
http://www.wikidata.org/entity/Q44798311
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Complete response of relapsed ...... ximab vedotin: 2 case reports.
@en
Complete response of relapsed ...... ximab vedotin: 2 case reports.
@nl
type
label
Complete response of relapsed ...... ximab vedotin: 2 case reports.
@en
Complete response of relapsed ...... ximab vedotin: 2 case reports.
@nl
prefLabel
Complete response of relapsed ...... ximab vedotin: 2 case reports.
@en
Complete response of relapsed ...... ximab vedotin: 2 case reports.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Complete response of relapsed ...... ximab vedotin: 2 case reports.
@en
P2093
P304
P31
P356
10.1016/J.CLML.2013.03.008
P407
P433
P478
P50
P577
P698